To explore whether BMP2 could serve as a substrate for the development of breast MCA, we compared the expression level of BMP2 in breast MCA with that in triple-negative breast cancer (TNBC) and the histology of IDC by immunohistochemistry. This evidence concerns the gene BMP2 and triple-negative breast carcinoma.